Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 689-696

  Peters, Christina ^a   Minkov, M ^a   Matthes Martin, S ^a   Potschger U ^a   Witt, V ^a   Mann, G ^a   Hocker P ^b   Worel, N ^b   Stary, J ^c   Klingebiel, T ^d   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Granulocytes; Infection; Leucocyte; RhG CSF; Transfusion

Indexed keywords

ANTINEOPLASTIC AGENT; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW APLASIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTIOUS COMPLICATION; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; LYMPHOCYTE COUNT; MALE; MALIGNANT NEOPLASTIC DISEASE; MYCOSIS; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; MALE; MYCOSES; NEOPLASMS; NEUTROPENIA; PREDNISOLONE; PROSPECTIVE STUDIES;

EID: 0032854510     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01619.x     Document Type: Article

References (27)

1. Adkins, D., Goodgold, H., Hendershott, L., Johnston, M., Cravens, D. & Spitzer, G. (1997) Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplantation, 19, 809-812.
2. Alavi, J.B., Root, R.K., Djerassi, I., Evans, A.E., Gluckman, S.J., MacGregor, R.R., Guerry, D., Schreiber, A.D., Shaw, J.M., Koch, P. & Cooper, R.A. (1977) A randomised clinical trial of granulocyte transfusions for infection in acute leukemia. New England Journal of Medicine, 296, 706-711.
3. Bensinger, W.I., Price, T.H., Dale, D.C., Appelbaum, F.R., Clift, R., Lilleby, K., Williams, B., Storb, R., Thomas, E.D. & Buckner, C.D. (1993) The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leucapheresis. Blood, 81, 1883-1888.
4. Bhatia, S., McCullough, J., Perry, E.H., Clay, M., Ramsay, N.K. & Neglia, J.P. (1994) Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion, 34, 226-232.
5. Bowden, R.A. (1995) Transfusion-transmitted cytomegalovirus infection. Hematolology/Oncology Clinics of North America, 9, 155-166.
6. Caspar, C.B., Seger, R.A., Burger, J. & Gmur, J. (1993) Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood, 81, 2866-2871.
7. Colotta, F., Re, F. & Mantovani, A. (1993) Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: also a question of cell survival? Blood, 82, 2258.
8. Dale, D.C., Fauci, A. & Guerry D, W.S. (1975) Comparison of agents producing a neutrophilic leukocytosis in man: hydrocortisone, prednisone, endotoxin and etiocholanolone. Journal of Clinical Investigation, 56, 808-813.
9. Dale, D.C., Liles, W.C., Llewellyn, C., Rodger, E. & Price, T.H. (1998) Neutrophil transfusions: kinetics and functions of neutrophils mobilised with granulocyte-colony-stimulating factor and dexamethasone. Transfusion, 38, 713-721.
10. Denning, D.W. (1994) Treatment of invasive aspergillosis. Journal of Infection, 28, (Suppl. 1), 25-33.
11. Dignani, M.C., Anaissie, E.J., Hester, J.P., O'Brien, S., Vartivarian, S.E., Rex, J.H., Kantarjian, H., Jendiroba, D.B., Lichtiger, B., Andersson, B.S. & Freireich, E.J. (1997) Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia, 11, 1621-1630.
12. Dutcher, J.P., Kendall, J., Norris, D., Schiffer, C., Aisner, J. & Wiernik, P.H. (1989) Granulocyte transfusion therapy and amphotericin B: adverse reactions? American Journal of Hematology, 31, 102-108.
13. Elting, L.S., Rubenstein, E.B., Rolston, K.V. & Bodey, G.P. (1997) Outcomes of bacteraemia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clinical Infectious Diseases, 25, 247-259.
14. Jendiroba, D.B., Lichtiger, B., Anaissie, E., Reed, E.C., O'Brien, S., Kantarjian, H. & Freireich, E.J. (1998) Evaluation and comparison of three mobilisation methods for the collection of granulocytes. Transfusion, 38, 722-728.
15. Kusne, S., Eibling, D.E., Yu, V.L., Fitz, D., Johnson, J.T., Kahl, L.E. & Ellis, L.D. (1988) Gangrenous cellulitis associated with Gram-negative bacilli in pancytopenic patients: dilemma with respect to effective therapy. American Journal of Medicine, 85, 490-494.
16. Liles, W.C., Huang, J.E., Llewellyn, C., San Gupta, D., Price, T.H. & Dale, D.C. (1997) A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion, 37, 182-187.
17. Link, H., Maschmeyer, G., Meyer, P., Hiddemann, W., Stille, W., Helmerking, M. & Adam, D. (1994) Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Annals of Hematology, 69, 231-243.
18. Maschmeyer, G., Link, H., Hiddemann, W., Meyer, P., Helmerking, M., Elsenmann, E., Schmitt, J. & Adam, D. (1994) Pulmonary infiltrations in febrile patients with neutropenia: risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer, 73, 2296-2304.
19. Morrison, V.A., Haake, R.J. & Weisdorf, D.J. (1994) Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. American Journal of Medicine, 96, 497-503.
20. Price, T.H. (1995) Blood centre perspective of granulocyte transfusions: future applications. Journal of Clinical Apheresis, 10, 119-123.
21. Rex, J.H., Bhalla, S.C., Cohen, D.M., Hester, J.P., Vartivarian, S.E. & Anaissie, E.J. (1995) Protection of human polymorphonuclear leucocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-gamma and granulocyte-colony-stimulating factor. Transfusion, 35, 605-611.
22. Saarinen, U.M., Hovi, L., Vilinikka, L., Juvonen, E. & Myllyla, G. (1995) Reemphasis on leucocyte transfusions: induction of myeloid marrow recovery in critically ill neutropenic children with cancer. Vox Sanguinis, 68, 90-99.
23. Strauss, R.G. (1993) Therapeutic granulocyte transfusions in 1993. Blood, 81, 1675-1678.
24. Stroncek, D.F., Leonard, K., Eiber, G., Malech, H.L., Gallin, J.I. & Leitman, S.F. (1996) Alloimmunization after granulocyte transfusions. Transfusion, 36, 1009-1015.
25. Takahashi, Y., Sugita, Y., Maruiwa, H., Hirohata, M., Tokutomi, T. & Shigemori, M. (1998) Fatal haemorrhage from rupture of the intracranial internal carotid artery caused by Aspergillus arteritis. Neurosurgery Reviews, 21, 198-201.
26. Tobias, J.D. & Schleien, C. (1991) Granulocyte transfusions: a review for the intensive care physician. Anaesthetics in Intensive Care, 19, 512-520.
27. Wright, D., Robiehaud, K.J., Pizzo, P.A. & Deisseroth, A.B. (1981) Lethal pulmonary reactions associated with the combined use of amphotericin B and leucocyte transfusions. New England Journal of Medicine, 304, 1185-1189.